<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sievers P</submitter><funding>Cancer Research UK</funding><funding>Hertie Network of Excellence in Clinical Neuroscience</funding><funding>The Brain Tumour Charity</funding><pagination>34-43</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7850075</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Malignant astrocytic gliomas in children show a remarkable biological and clinical diversity. Small in-frame insertions or missense mutations in the epidermal growth factor receptor gene (EGFR) have recently been identified in a distinct subset of pediatric-type bithalamic gliomas with a unique DNA methylation pattern.&lt;h4>Methods&lt;/h4>Here, we investigated an epigenetically homogeneous cohort of malignant gliomas (n = 58) distinct from other subtypes and enriched for pediatric cases and thalamic location, in comparison with this recently identified subtype of pediatric bithalamic gliomas.&lt;h4>Results&lt;/h4>EGFR gene amplification was detected in 16/58 (27%) tumors, and missense mutations or small in-frame insertions in EGFR were found in 20/30 tumors with available sequencin</pubmed_abstract><journal>Neuro-oncology</journal><pubmed_title>A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.</pubmed_title><pmcid>PMC7850075</pmcid><funding_grant_id>16/193</funding_grant_id><funding_grant_id>23536</funding_grant_id><pubmed_authors>Kramm CM</pubmed_authors><pubmed_authors>Stichel D</pubmed_authors><pubmed_authors>Pfister SM</pubmed_authors><pubmed_authors>Solomon DA</pubmed_authors><pubmed_authors>Sievers P</pubmed_authors><pubmed_authors>Sturm D</pubmed_authors><pubmed_authors>Korshunov A</pubmed_authors><pubmed_authors>Wesseling P</pubmed_authors><pubmed_authors>Jones C</pubmed_authors><pubmed_authors>Schrimpf D</pubmed_authors><pubmed_authors>Castel D</pubmed_authors><pubmed_authors>Snuderl M</pubmed_authors><pubmed_authors>Witt O</pubmed_authors><pubmed_authors>Hench J</pubmed_authors><pubmed_authors>Reuss DE</pubmed_authors><pubmed_authors>Harter PN</pubmed_authors><pubmed_authors>Jabado N</pubmed_authors><pubmed_authors>Reifenberger G</pubmed_authors><pubmed_authors>Frank S</pubmed_authors><pubmed_authors>Vicha A</pubmed_authors><pubmed_authors>Debily MA</pubmed_authors><pubmed_authors>von Deimling A</pubmed_authors><pubmed_authors>Jacques TS</pubmed_authors><pubmed_authors>Jones DTW</pubmed_authors><pubmed_authors>Zapotocky M</pubmed_authors><pubmed_authors>Perry A</pubmed_authors><pubmed_authors>Krskova L</pubmed_authors><pubmed_authors>Sahm F</pubmed_authors><pubmed_authors>Grill J</pubmed_authors><pubmed_authors>Wick W</pubmed_authors><pubmed_authors>Bison B</pubmed_authors><pubmed_authors>Sill M</pubmed_authors></additional><is_claimable>false</is_claimable><name>A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.</name><description>&lt;h4>Background&lt;/h4>Malignant astrocytic gliomas in children show a remarkable biological and clinical diversity. Small in-frame insertions or missense mutations in the epidermal growth factor receptor gene (EGFR) have recently been identified in a distinct subset of pediatric-type bithalamic gliomas with a unique DNA methylation pattern.&lt;h4>Methods&lt;/h4>Here, we investigated an epigenetically homogeneous cohort of malignant gliomas (n = 58) distinct from other subtypes and enriched for pediatric cases and thalamic location, in comparison with this recently identified subtype of pediatric bithalamic gliomas.&lt;h4>Results&lt;/h4>EGFR gene amplification was detected in 16/58 (27%) tumors, and missense mutations or small in-frame insertions in EGFR were found in 20/30 tumors with available sequencin</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2026-04-08T13:53:01.103Z</modification><creation>2022-02-11T12:24:33.3Z</creation></dates><accession>S-EPMC7850075</accession><cross_references><pubmed>33130881</pubmed><doi>10.1093/neuonc/noaa251</doi></cross_references></HashMap>